Fiji faces a catastrophic rise in HIV cases, especially among the youth, driven by drug use and dangerous practices like 'bluetoothing'. Experts warn of an impending healthcare crisis.
A groundbreaking injectable HIV prevention drug will be available for just $40 a year in over 100 countries by 2027, thanks to agreements between Unitaid, the Gates Foundation, and Indian pharmaceutical companies.
A new study warns that up to 2.9 million more people could die from HIV-related causes by 2030 due to significant cuts in international aid. Researchers urge immediate action to prevent a resurgence of the HIV epidemic.
In a surprising turn, the Trump administration has terminated key funding for HIV programs aimed at adolescents, raising concerns over the future of HIV prevention efforts in the U.S.
The Trump administration is reportedly discussing potential cuts to the CDC’s domestic HIV program, sparking concerns over the future of HIV prevention efforts across the U.S. Advocates warn about the implications for testing and outreach as the administration seeks to streamline federal spending.
